$ABVC BioPharma (ABVC.US)$  - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...

$WISeKey (WKEY.US)$ $SEALSQ Corp (LAES.US)$
WISeKey and SEALSQ Announce Prestigious Speaker Line-Up and Agenda for Davos 2025 Roundtable: Celebrating 20 Years of Pioneering Innovation
WISeKey (NASDAQ: WKEY) and SEALSQ(NASDAQ: LAES) announced their upcoming Davos 2025 Roundtable, marking WISeKey's 20th consecutive year at the Davos forum. The event, themed 'Pioneering Innovation: Cybersecurity and Beyond,' will take place on January 22, 2025, at the Morosani Schweizerhof hotel in Davos, Switzerl...

$Beyond Air (XAIR.US)$
Beyond Air Receives CE Mark in Europe for the LungFit® PH System
Monday, 2nd December at 7:30 am
Indication covers newborn infants with hypoxic respiratory failure and peri- and post-operative pulmonary hypertension to improve right ventricular function in conjunction with heart surgery
A $1 million milestone payment is triggered from Asia-Pacific partner, Getz Healthcare

BTIG analyst Julian Harrison maintains $Outlook Therapeutics (OTLK.US)$ with a buy rating, and adjusts the target price from $50 to $9.

Its Friday with shorter trading time. Sleepy already. Some will run and some will get delayed market reaction.
$Applied Therapeutics (APLT.US)$ Crashed after FDA CRL but will resubmit. Dropped from 10 to 1.3 rebounded to 1.95. SI 16%
$PainReform (PRFX.US)$ Microfloat. Up after hours. SI 20%. 0 shares LTB. CTB 436%. If there is no catalyst, microfloats will be a quick play.✔️
$Blue Ocean Acquisition Corp(Delisted) (BOCN.US)$ Merger ...

$SciSparc (SPRC.US)$ SciSparc Ltd. has announced a second addendum to its merger agreement with AutoMax Motors Ltd., extending the deadline for the merger completion to March 31, 2025.